Alopecia Areata-Part III: Prognosis and Treatment.

Juliany Estefan, Marcia Ribeiro, Eliane Abad, Simone Saintive, Marcia Ramos-E-Silva

Review Skinmed 2016 2 인용

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D27871349'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

연구 유형: Review
대상 집단: alopecia areata patients

중재: Alopecia Areata-Part III: Prognosis and Treatment. None
대조군: None
일차 결과: None
효과 방향: Mixed
비뚤림 위험: Unclear

Abstract

The prognosis of alopecia areata is better in cases with single and small lesions, and the variability of the extension of the disease is one of the criteria for the choice of treatment modality. Several medications have been described in the literature for the treatment of alopecia areata, including corticosteroids, minoxidil, and diphencyprone. The authors review treatments for alopecia areata.

요약

The prognosis of alopecia areata is better in cases with single and small lesions, and the variability of the extension of the disease is one of the criteria for the choice of treatment modality.

Used In Evidence Reviews

A 미녹시딜 관련 원형 탈모증

Alopecia Areata-Part III: Prognosis and Treatment.

Embed This Widget

Study Design

Abstract

요약

Used In Evidence Reviews

Similar Papers

Secular trends in dietary intake in the United States.

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.

The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.

Alopecia areata.

Minoxidil and its use in hair disorders: a review.

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.